GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ThermoGenesis Holdings Inc (STU:THR) » Definitions » E10

ThermoGenesis Holdings (STU:THR) E10 : €-1,205.06 (As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is ThermoGenesis Holdings E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

ThermoGenesis Holdings's adjusted earnings per share data for the three months ended in Mar. 2024 was €-0.423. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-1,205.06 for the trailing ten years ended in Mar. 2024.

During the past 3 years, the average E10 Growth Rate was 11.50% per year. During the past 5 years, the average E10 Growth Rate was 10.40% per year. During the past 10 years, the average E10 Growth Rate was 11.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of ThermoGenesis Holdings was 18.90% per year. The lowest was -2.30% per year. And the median was 5.90% per year.

As of today (2024-05-25), ThermoGenesis Holdings's current stock price is €0.525. ThermoGenesis Holdings's E10 for the quarter that ended in Mar. 2024 was €-1,205.06. ThermoGenesis Holdings's Shiller PE Ratio of today is .


ThermoGenesis Holdings E10 Historical Data

The historical data trend for ThermoGenesis Holdings's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ThermoGenesis Holdings E10 Chart

ThermoGenesis Holdings Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,892.28 -1,656.64 -1,715.72 -1,826.95 -1,370.16

ThermoGenesis Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,692.31 -1,490.36 -1,431.86 -1,370.16 -1,205.06

Competitive Comparison of ThermoGenesis Holdings's E10

For the Medical Devices subindustry, ThermoGenesis Holdings's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ThermoGenesis Holdings's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ThermoGenesis Holdings's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where ThermoGenesis Holdings's Shiller PE Ratio falls into.



ThermoGenesis Holdings E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, ThermoGenesis Holdings's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.423/131.7762*131.7762
=-0.423

Current CPI (Mar. 2024) = 131.7762.

ThermoGenesis Holdings Quarterly Data

per share eps CPI Adj_EPS
201406 -529.920 100.560 -694.423
201409 -558.720 100.428 -733.124
201412 -802.890 99.070 -1,067.953
201503 -989.604 99.621 -1,309.022
201506 -469.111 100.684 -613.978
201509 -669.586 100.392 -878.914
201512 -123.930 99.792 -163.650
201603 -1,616.400 100.470 -2,120.058
201606 -491.429 101.688 -636.836
201609 -1,487.524 101.861 -1,924.390
201612 -149.310 101.863 -193.157
201703 -88.357 102.862 -113.194
201706 -4.005 103.349 -5.107
201709 -90.612 104.136 -114.663
201712 3.802 104.011 4.817
201803 -98.536 105.290 -123.324
201806 -673.715 106.317 -835.048
201809 -45.121 106.507 -55.826
201812 -66.057 105.998 -82.122
201903 -30.267 107.251 -37.188
201906 -18.718 108.070 -22.824
201909 -31.871 108.329 -38.769
201912 -55.080 108.420 -66.945
202003 -45.205 108.902 -54.700
202006 -40.759 108.767 -49.381
202009 -14.136 109.815 -16.963
202012 -8.878 109.897 -10.646
202103 -7.938 111.754 -9.360
202106 -14.193 114.631 -16.316
202109 -5.738 115.734 -6.533
202112 -8.947 117.630 -10.023
202203 -6.020 121.301 -6.540
202206 -8.495 125.017 -8.954
202209 -4.707 125.227 -4.953
202212 -3.125 125.222 -3.289
202303 -3.801 127.348 -3.933
202306 -0.840 128.729 -0.860
202309 -1.349 129.860 -1.369
202312 -2.137 129.419 -2.176
202403 -0.423 131.776 -0.423

Add all the adjusted EPS together and divide 10 will get our e10.


ThermoGenesis Holdings  (STU:THR) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


ThermoGenesis Holdings E10 Related Terms

Thank you for viewing the detailed overview of ThermoGenesis Holdings's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


ThermoGenesis Holdings (STU:THR) Business Description

Traded in Other Exchanges
Address
2711 Citrus Road, Rancho Cordova, CA, USA, 95742
ThermoGenesis Holdings Inc develops, commercializes and markets a range of automated technologies for CAR-T and other cell-based therapies. The company currently markets a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally-closed CAR-TXpress platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. It offers the AutoXpress and BioArchive platforms for automated clinical bio-banking, PXP platform for point-of-care cell-based therapies and CAR-TXpress platform for bio-manufacturing for immuno-oncology applications.